Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Ken Banta

Founder and CEO, The Vanguard Network

Articles by Ken Banta

Navigating the Complexities of a Global Pharma Expansion

October 20th 2025

A case study in leading and guiding a cultural reset and strategic revival.

Latest Updated Articles

Trending on PharmExec

Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro

FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps

Navigating the Complexities of a Global Pharma Expansion

© 2025 MJH Life Sciences^®

All rights reserved.